Patent Expiry

Patent/Exclusivity Expiry: VYKOURA

Other upcoming events for INBX

Phase 3 ReadoutPhase 3 Topline: A Phase 2/3, Randomized Study of INBRX-106 Combined With Pembrolizumab Versus Pembrolizumab as First
Patent ExpiryPatent/Exclusivity Expiry: KHAPZORY

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Patent/Exclusivity Expiry: VYKOURA — INBX Patent Expiry | BioSniper